| 2-AG | 2-arachidonoylglycerol |
| AEA | anandamide |
| AUC | area under the curve |
| BHB | β-hydroxybutyrate |
| BMI | body mass index |
| BMR | basal metabolic rate |
| CB1 | cannabinoid receptor 1 |
| CB2 | cannabinoid receptor 2 |
| dAUC | decremental area under the curve |
| EDTA | ethylenediaminetetraacetic acid |
| EI | energy intake |
| FFM | fat-free mass |
| FM | fat mass |
| GC-MS | gas chromatography-mass spectrometry |
| GC-MS/MS | gas chromatography-tandem mass spectrometry |
| GI | glycemic index |
| GLP-1 | glucagon-like peptide-1 |
| HOMA-IR | homeostatic model assessment for insulin resistance |
| HP/MCHO | high protein/ moderate carbohydrate |
| iAUC | incremental area under the curve |
| MJ | megajoule |
| mmVAS | milimeter visiual analogue scale |
| MP/ HCHO | moderate-protein/ high-carbohydrate |
| OEA | oleoylethanolamide |
| OGTT | oral glucose tolerance test |
| PEA | palmitoylethanolamide |
| PMSF | phenylmethylsulfonyl fluoride |
| PREG | pregnenolone |
| PYY | polypeptide YY |
| TAG | triacylglycerol |
| T2D | type II diabetes |
| VAS | visual analogue scale |